Although obinutuzumab has not yet received FDA approval in lupus nephritis, findings from a recent survey conducted by ...

The new company will work on five experimental drugs licensed from Bristol Myers, including a late-stage lupus treatment and ...

Pennsylvania promised a better mental health system in 2011. But the failure to follow through has created dire consequences ...

Trigeminal neuralgia (TN) is a severe facial pain condition affecting the trigeminal nerve, often misdiagnosed and causing ...

Everyone living in a state psychiatric hospital would come home. No longer would having a serious mental health condition ...

Q2 2025 Earnings Call Transcript July 31, 2025 Biogen Inc. misses on earnings expectations. Reported EPS is $ EPS, ...

Spotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism ...

As Merck & Co. rolls out a widespread cost-cutting initiative, the pharma is dropping an autoimmune asset acquired a few years ago in a nearly $2 billion biotech takeover.

Q2 2025 Earnings Call Transcript July 31, 2025 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...

Experts say combining functional medicine with cosmetic procedures delivers lasting, natural-looking results. Here’s how this ...

Detailed price information for Aurinia Pharm Ord (AUPH-Q) from The Globe and Mail including charting and trades.

Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response. The Independent Data Monitoring Commi ...